Accede al análisis completo con tu suscripción
Últimos 20 reportes · 10-K · 10-K/A · 10-Q · 8-K · Fuente: SEC EDGAR
Accede al análisis completo con tu suscripción
SEC CIK: 0001792044
Viatris is a global healthcare company whose breadth and scale we believe make it uniquely positioned to address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, Viatris supplies high-quality medicines to approximately 1 billion patients around the world each year. The Company has a global footprint, an extensive portfolio of medicines that is well-diversified across therapeutic areas, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges. Viatris’ executive management team is focused on ensuring that the Company is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers and other key stakeholders. The Company operates in more than 165 countries and territories with more than 30,000 employees. The Company has 27 manufacturing, packaging, and distribution sites worldwide, more than 1,400 approved molecules, and what we believe is industry leading commercial, R&D, regulatory, manufacturing, legal and medical expertise.
Ver másPrecio actual · USD
$16.34
Consenso de Analistas
Precio Objetivo — 12 meses
$12.00
Mínimo
-26.6%
$19.00
Mediana
+16.3%
$18.50
Promedio
+13.2%
$23.00
Máximo
+40.8%
P/E LTM
—
Precio / EPS LTM diluido
Gross Margin
34.9%
Gross profit / Ingresos
Operating Margin
-0.6%
Op. income / Ingresos
Amort. Intang / Revenue
16.0%
Amort. intangibles / Ingresos
FCF Margin
13.3%
FCF / Ingresos
ROE (avg equity)
-2.8%
Benef. neto / Patrimonio
ROA (avg assets)
-1.1%
Benef. neto / Activo total
Margen Neto
-2.8%
Benef. neto / Ingresos
| Métrica | LTM jun 26 | 2025 | 2024 | 2023 | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium |
|---|---|---|---|---|---|---|---|---|---|
| INGRESOS Y MÁRGENES | |||||||||
| Ingresos Totales | 14.694B | 14.250B | 14.693B | 15.388B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Cost of Revenue | 9.604B | 9.286B | 9.116B | 8.988B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Profit | 5.133B | 5.013B | 5.624B | 6.439B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Margin | 34.9% | 35.2% | 38.3% | 41.8% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| GASTOS OPERATIVOS | |||||||||
| SG&A | 3.981B | 3.794B | 4.105B | 4.070B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Amortización Intangibles | 2.352B | 2.350B | 2.352B | 2.317B | 🔒 | 🔒 | 🔒 | 🔒 | |
| STOCK-BASED COMPENSATION | |||||||||
| Stock-Based Compensation | 172.300M | 177.700M | 146.100M | 180.700M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SBC / Revenue | 1.2% | 1.3% | 1.0% | 1.2% | 🔒 | 🔒 | 🔒 | 🔒 | |
| RESULTADO NETO | |||||||||
| Pretax Income | -662.200M | -3.665B | -623.200M | 202.900M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Interest Expense (P&L) | 480.000M | 471.300M | 550.000M | 573.100M | 🔒 | 🔒 | 🔒 | 🔒 | |
| INVENTARIO Y LEASE | |||||||||
| Inventario Neto | 3.933B | 3.999B | 3.854B | 3.470B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| LIQUIDEZ | |||||||||
| Cash & Equivalentes | 886.500M | 1.322B | 734.800M | 991.900M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Total Liquid Assets | 886.500M | 1.322B | 734.800M | 991.900M | 🔒 | 🔒 | 🔒 | 🔒 | |
| BALANCE — ACTIVOS | |||||||||
| PP&E Neto | 2.440B | 2.614B | 2.666B | 2.760B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Goodwill | 6.654B | 6.755B | 9.133B | 9.867B | 🔒 | 🔒 | 🔒 | 🔒 | |
| CAPITAL Y DEUDA | |||||||||
| Deuda Total | 13.349B | 14.411B | 14.040B | 18.123B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Net Debt | 12.462B | 13.088B | 13.305B | 17.131B | 🔒 | 🔒 | 🔒 | 🔒 | |
| FLUJO DE CAJA Y CAPEX | |||||||||
| Cash Flow Operativo (CFO) | 2.331B | 2.316B | 2.303B | 2.900B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Capex | 376.000M | 378.800M | 326.000M | 377.000M | 🔒 | 🔒 | 🔒 | 🔒 | |
| RATIOS | |||||||||
| ROIC (NOPAT / IC) | — | — | — | 1.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Margin | 34.9% | 35.2% | 38.3% | 41.8% | 🔒 | 🔒 | 🔒 | 🔒 | |
Cifras en miles de millones (B) · Fuente: SEC/EDGAR
| 🔒 |
| Amort. Intang / Revenue | 16.0% | 16.5% | 16.0% | 15.1% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Income | -87.300M | -2.663B | 10.100M | 766.200M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Margin | -0.6% | -18.7% | 0.1% | 5.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| Tax Expense | -251.500M | -150.100M | 11.000M | 148.200M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Beneficio Neto | -410.700M | -3.515B | -634.200M | 54.700M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | -2.8% | -24.7% | -4.3% | 0.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Diluido | -0.37 | -3.00 | -0.53 | 0.05 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Básico | -0.37 | -3.00 | -0.53 | 0.05 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| Intangibles | 13.677B | 15.102B | 17.071B | 19.181B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Activo Total | 35.045B | 37.193B | 41.501B | 47.685B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Pasivo Total | 20.784B | 22.482B | 22.865B | 27.218B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| Patrimonio Neto | 14.260B | 14.711B | 18.636B | 20.467B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Invested Capital | 27.609B | 30.898B | 35.633B | 39.464B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Acciones en Circulación | 1.149B | — | — | 1.207B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| Free Cash Flow (FCF) | 1.955B | 1.937B | 1.977B | 2.523B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| FCF Margin | 13.3% | 13.6% | 13.4% | 16.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| NOPAT | — | — | — | 383.100M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Recompras de acciones | 300.100M | 500.500M | 250.000M | 250.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Dividendos por acción | 0.48 | 0.48 | 0.48 | 0.12 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Adquisiciones (Business) | 0.00 | 0.00 | 350.000M | 667.700M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| Operating Margin | -0.6% | -18.7% | 0.1% | 5.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Amort. Intang / Revenue | 16.0% | 16.5% | 16.0% | 15.1% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| FCF Margin | 13.3% | 13.6% | 13.4% | 16.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROE (avg equity) | -2.8% | -21.1% | -3.2% | 0.3% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROA (avg assets) | -1.1% | -8.9% | -1.4% | 0.1% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | -2.8% | -24.7% | -4.3% | 0.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Debt / Equity Ratio | 0.94x | 0.98x | 0.75x | 0.89x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |